Skip navigation

Podcasts

February 2012 podcast

This month, we find out about a fluorescent dye could light up the early signs of oesophageal cancer, and how a faulty gene has been unexpectedly linked to better survival from ovarian cancer. Plus, our chief clinician responds to the decision by NICE to reject a new prostate cancer drug on grounds of cost, and we hear about a new drug trial to treat childhood leukaemia. 

And finally, we've got an exclusive interview with our chief executive Dr Harpal Kumar as Cancer Research UK celebrates its tenth birthday, looking back on the progress we've made and the challenges in store for the next decade.

Download: February 2012 podcast

Transcript: February 2012 podcast transcript

Or

Subscribe: to the podcast using the orange button on the right hand side.

You can also get the Cancer Research UK podcast from iTunes, if it is installed on your computer.

Recent podcasts

January 2012 podcast

This month - funding boosted for UK cancer trials, 100 days until tobacco displays are removed, scientists uncover breast cancer clues, processed meat increases pancreatic cancer risk, we look at the latest progress in immunotherapy, and finally, there's a glimpse of what 2012 holds for Cancer Research UK.

December 2011 podcast

This month: our Stratified Medicine Programme starts recruiting patients, researchers target a key cancer protein, we launch nine high tech gene projects, more lung cancer patients need surgery to survive, the biggest report to date on lifestyle and cancer, and we celebrate the bravery of our Little Stars.

November 2011 podcast

This month we bring you news from the National Cancer Research Institute conference in Liverpool - the UK's biggest cancer conference. Plus advice on diet and weight could help bowel cancer patients, research reveals that lifestyle affects the chances of suffering side effects from prostate cancer treatment, and we listen in on a discussion at the conference between two top cancer doctors, as they discuss cancer care on both sides of the Atlantic.

October 2011 podcast

This month: a new prostate cancer drug is licensed in the UK, red tape hinders cancer trials, HPV testing could save thousands of unnecessary cancer tests, beta-blockers could prevent cancer spread, new research on vitamin D, and we say goodbye to an amazing kid.